<unk>  is an interleukin-1 blocker that is FDA approved for the treatment of cryopyrin-associated periodic syndromes (CAPS), including familial cold auto-inflammatory syndrome (FCAS) and muckle-wells syndrome (MWS) in adults and children 12 and older.   Common adverse reactions include injection-site reactions and upper respiratory tract infections.
Rilonacept
Diprenorfin
Rivastigmine
Rivastigmine 
Memantine
Belinostat
Adrafinil
Donepezil